This topic contains a solution. Click here to go to the answer

Author Question: What onset of action symptoms should be reviewed with patients who have been newly prescribed a ... (Read 46 times)

sam.t96

  • Hero Member
  • *****
  • Posts: 570
What onset of action symptoms should be reviewed with patients who have been newly prescribed a selective serotonin reuptake inhibitor?
 
  1. They will have insomnia for a week.
  2. They can feel a bit of nausea, but this resolves in a week.
  3. They will have an onset seizure but this is considered normal.
  4. They will no longer dream.

Question 2

Which of the following should not be taken with a selective serotonin reuptake inhibitor?
 
  1. Aged blue cheese
  2. Grapefruit
  3. Alcohol
  4. Green leafy vegetables



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

mohan

  • Sr. Member
  • ****
  • Posts: 362
Answer to Question 1

2

Answer to Question 2

3




sam.t96

  • Member
  • Posts: 570
Reply 2 on: Jul 24, 2018
Great answer, keep it coming :)


T4T

  • Member
  • Posts: 348
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

Did you know?

Vaccines prevent between 2.5 and 4 million deaths every year.

Did you know?

People who have myopia, or nearsightedness, are not able to see objects at a distance but only up close. It occurs when the cornea is either curved too steeply, the eye is too long, or both. This condition is progressive and worsens with time. More than 100 million people in the United States are nearsighted, but only 20% of those are born with the condition. Diet, eye exercise, drug therapy, and corrective lenses can all help manage nearsightedness.

Did you know?

According to the National Institute of Environmental Health Sciences, lung disease is the third leading killer in the United States, responsible for one in seven deaths. It is the leading cause of death among infants under the age of one year.

Did you know?

Patients who have undergone chemotherapy for the treatment of cancer often complain of a lack of mental focus; memory loss; and a general diminution in abilities such as multitasking, attention span, and general mental agility.

For a complete list of videos, visit our video library